10-Q quarterly report · filed Nov 5, 2026

LifeStance Health Group, Inc. (LFST) Q3 2026 10-Q Quarterly Report

Short answer

LifeStance Health Group, Inc. (LFST) filed its Q3 2026 10-Q quarterly report on Nov 5, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $456M (up 25.3% year over year) with net income of $22M.

Q3 2026 key financials · XBRL

Revenue
$456M
+25.3% YoY · +4.7% QoQ
Net income
$22M
+1978.5% YoY · −5.2% QoQ
Operating margin
7.3%

Source: XBRL data from the LifeStance Health Group, Inc. (LFST) Q3 2026 10-Q on SEC EDGAR. USD.

LifeStance Health Group, Inc. Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Revenue $455.9M, up 25% YoY from $363.8M, driven by 17% higher visits and modest payor rate increases
  • Operating margin 7.3% vs 2.0% YoY, with income from operations $33.1M vs $7.4M
  • Center Margin $161.4M vs $116.6M, up 38%; Adjusted EBITDA $68.4M vs $40.2M
  • Nine-month operating cash flow $170.0M vs $88.6M; share repurchases $24.8M during the quarter
  • Outlook: revenue growth from clinician recruiting, acquisitions, new centers and virtual sessions; near-term center and G&A investment headwinds

Risk Factors

  • Ownership concentration: TPG and Summit collectively own approximately 25.3%, limiting stockholder influence over control transactions
  • Governance transition: Loss of Nasdaq controlled-company status triggered phased independent committee requirements over one year
  • Compliance exposure: Governance exemptions remain available during the transition, reducing stockholder protections
  • Conflict risk: Principal Stockholders may invest in competitors or pursue acquisitions unavailable to LifeStance

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other LifeStance Health Group, Inc. quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.